House Oversight Subcmte. hearing on alleged FDA retaliation tentatively set for July 25.
This article was originally published in The Tan Sheet
Executive Summary
HOUSE OVERSIGHT SUBCOMMITTEE HEARING ON PERCEIVED FDA RETALIATION is tentatively set for July 25. The House Commerce/Over-sight Subcommittee hearing will focus on the belief that an adversarial relationship exists between FDA and the companies it regulates, with particular emphasis on allegations that the agency retaliates against its critics.